Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

MLA

Zanchetti, Alberto, et al. “Continuation of the ESH-CHL-SHOT Trial after Publication of the SPRINT: Rationale for Further Study on Blood Pressure Targets of Antihypertensive Treatment after Stroke.” Journal of Hypertension, vol. 34, no. 3, Mar. 2016, pp. 393–96. EBSCOhost, https://doi.org/10.1097/HJH.0000000000000853.

APA

Zanchetti, A., Liu, L., Mancia, G., Parati, G., Grassi, G., Stramba-Badiale, M., Silani, V., Bilo, G., Corrao, G., Zambon, A., Scotti, L., Zhang, X., Guan, T. R., Zhang, Y., Zhang, X., Berge, E., Redon, J., Narkiewicz, K., Dominiczak, A., … Ford, G. (2016). Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. Journal of Hypertension, 34(3), 393–396. https://doi.org/10.1097/HJH.0000000000000853

Chicago

Zanchetti, Alberto, Lisheng Liu, Giuseppe Mancia, Gianfranco Parati, Guido Grassi, Marco Stramba-Badiale, Vincenzo Silani, et al. 2016. “Continuation of the ESH-CHL-SHOT Trial after Publication of the SPRINT: Rationale for Further Study on Blood Pressure Targets of Antihypertensive Treatment after Stroke.” Journal of Hypertension 34 (3): 393–96. doi:10.1097/HJH.0000000000000853.